Lung vascular targeting through inhalation delivery: Insight from filamentous viruses and other shapes

IUBMB Life

Volumn 63, Issue 8, 2011, Pages 607-612

  Mahmud, Abdullah ^a   Discher, Dennis E ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

filamentous virus; filomicelles; inhalation; nanoparticle; systemic delivery; translocation; vascular targeting

Indexed keywords

CALCITONIN; CYCLOSPORIN A; CYTOKINE; HUMAN GROWTH HORMONE; INTERFERON; NANOCONJUGATE; NANOPARTICLE; PARATHYROID HORMONE; POLYMER; RECOMBINANT HUMAN INSULIN; SALCATONIN;

DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG TRANSPORT; HUMAN; INFLUENZA VIRUS; INHALATION; LUNG BLOOD VESSEL; MICELLE; NONHUMAN; PARTICLE SIZE; REVIEW;

ADMINISTRATION, INHALATION; HUMANS; LUNG; ORTHOMYXOVIRIDAE;

ORTHOMYXOVIRIDAE;

EID: 79960795906     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.481     Document Type: Review

References (57)

1. Patton, J. S., and, Byron, P. R., (2007) Inhaling medicines: delivering drugs to the body through the lungs. Nat. Rev. Drug Discov. 6, 67-74. (Pubitemid 46020287)
2. Patton, J. S., Bukar, J. G., and, Eldon, M. A., (2004) Clinical pharmacokinetics and pharmacodynamics of inhaled insulin. Clin. Pharmacokinet. 43, 781-801. (Pubitemid 39382220)
3. Quattrin, T., Belanger, A., Bohannon, N. J. V., Schwartz, S. L., and, Exubera Phase, I. I. I. S. G., (2004) Efficacy and safety of inhaled insulin (exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes-results of a 6-month, randomized, comparative trial. Diabetes Care 27, 2622-2627. (Pubitemid 39441461)
4. Agu, R. U., Ugwoke, M. I., Armand, M., Kinget, R., and, Verbeke, N., (2001) The lung as a route for systemic delivery of therapeutic proteins and peptides. Resp. Res. 2, 198-209. (Pubitemid 34187927)
5. Patton, J. S., (1997) Deep-lung delivery of therapeutic proteins. Chemtech 27, 34-38. (Pubitemid 127546012)
6. Damms, B., and, Bains, W., (1995) The cost of delivering drdugs without needles. Bio-Technology 13, 1438-1440.
7. Wang, J., Ben-Jebria, A., and, Edwards, D. A., (1999) Inhalation of estradiol for sustained systemic delivery. J. Aerosol. Med. 12, 27-36. (Pubitemid 29109297)
8. Patton, J. S., (1996) Mechanisms of macromolecule absorption by the lungs. Adv. Drug Deliver. Rev. 19, 3-36. (Pubitemid 26167852)
9. Shortridge, K. F., Zhou, N. N., Guan, Y., Gao, P., Ito, T., Kawaoka, Y., Kodihalli, S., Krauss, S., Markwell, D., Murti, K. G., Norwood, M., Senne, D., Sims, L., Takada, A., and, Webster, R. G,. (1998) Characterization of avian H5N1 influenza viruses from poultry in Hong Kong. Virology 252, 331-342. (Pubitemid 29013415)
10. Roberts, P. C., Lamb, R. A., and, Compans, R. W., (1998) The M1 and M2 proteins of influenza A virus are important determinants in filamentous particle formation. Virology 240, 127-137. (Pubitemid 28394131)
11. Smola, M., Vandamme, T., and, Sokolowski, A., (2008) Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases. Int. J. Nanomed. 3, 1-19. (Pubitemid 351517072)
12. Bailey, M. M., and, Berkland, C. J., (2009) Nanoparticle formulations in pulmonary drug delivery. Med. Res. Rev. 29, 196-212.
13. Edwards, D. A., Hanes, J., Caponetti, G., Hrkach, J., BenJebria, A., Eskew, M. L., Mintzes, J., Deaver, D., Lotan, N., and, Langer, R,. (1997) Large porous particles for pulmonary drug delivery. Science 276, 1868-1871. (Pubitemid 27443665)
14. Edwards, D. A., Ben-Jebria, A., and, Langer, R., (1998) Recent advances in pulmonary drug delivery using large, porous inhaled particles. J. Appl. Physiol. 85, 379-385. (Pubitemid 28365799)
15. Vanbever, R., Mintzes, J. D., Wang, J., Nice, J., Chen, D. H., Batycky, R., Langer, R., and, Edwards, D. A,. (1999) Formulation and physical characterization of large porous particles for inhalation. Pharm. Res. 16, 1735-1742. (Pubitemid 29530407)
16. Lippmann, M., Yeates, D. B., and, Albert, R. E., (1980) Deposition, retention, and clearance of inhaled particles. Brit. J. Ind. Med. 37, 337-362. (Pubitemid 11215084)
17. Heyder, J., Gebhart, J., Rudolf, G., Schiller, C. F., and, Stahlhofen, W., (1986) Deposition of particles in the human respiratory tract in the size-ranges 0.005-15 μm. J. Aersol. Sci. 17, 811-825. (Pubitemid 17492310)
18. Sung, J. C., Pulliam, B. L., and, Edwards, D. A., (2007) Nanoparticles for drug delivery to the lungs. Trends Biotechnol. 25, 563-570. (Pubitemid 350138179)
19. Ehlers, M., Silagy, C., Fleming, D., and, Freeman, D., (2001) New approaches for managing influenza in primary care. Clin. Drug Invest. 21, 443-452. (Pubitemid 32553608)
20. Dershwitz, M., Walsh, J. L., Morishige, R. J., Conners, P. M., Rubsamen, R. M., Shafer, S. L., Rosow, C. E,. (2000) Pharmacokinetics and pharmacodynamics of inhaled versus intravenous morphine in healthy volunteers. Anesthesiology 93, 619-628.
21. Brown, R. A., and, Schanker, L. S., (1983) Absroption of aerosolized drugs from the rat lung. Drug Metab. Dispos. 11, 355-360. (Pubitemid 13035486)
22. Schanker, L. S., Mitchell, E. W., and, Brown, R. A., (1986) Species composition of drug absorption from the lung after aersol inhalation or intratracheal injection. Drug Metab. Dispos. 14, 79-88. (Pubitemid 16152318)
23. Fu, J., Fiegel, J., Krauland, E., and, Hanes, J., (2002) New polymeric carriers for controlled drug delivery following inhalation or injection. Biomaterials 23, 4425-4433.
24. Tseng, C. L., Wu, S. Y. H., Wang, W. H., Peng, C. L., Lin, F. H., Lin, C. C., Young, T. H., and, Shieh, M. J,. (2008) Targeting efficiency and biodistribution of biotinylated-EGF-conjugated gelatin nanoparticles administered via aerosol delivery in nude mice with lung cancer. Biomaterials 29, 3014-3022.
25. Tang, B. C., Fu, J., Watkins, D. N., and, Hanes, J., (2010) Enhanced efficacy of local etoposide delivery by poly(ether-anhydride) particles against small cell lung cancer in vivo. Biomaterials 31, 339-344.
26. Tseng, C. L., Su, W. Y., Yen, K. C., Yang, K. C., and, Lin, F. H., (2009) The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation. Biomaterials 30, 3476-3485.
27. Huang, Y. Y., and, Wang, C. H., (2006) Pulmonary delivery of insulin by liposomal carriers. J. Control. Release 113, 9-14.
28. Garbuzenko, O. B., Saad, M., Pozharov, V. P., Reuhl, K. R., Mainelis, G., and, Minko, T,. (2010) Inhibition of lung tumor growth by complex pulmonary delivery of drugs with oligonucleotides as suppressors of cellular resistance. Proc. Natl. Acad. Sci. USA 107, 10737-10742.
29. Ungaro, F., Bianca, R., Giovino, C., Miro, A., Sorrentino, R., Quaglia, F., and, La Rotonda, M. I,. (2009) Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs. J. Control. Release 135, 25-34.
30. Knowles, M. R., and, Boucher, R. C., (2002) Mucus clearance as a primary innate defense mechanism for mammalian airways. J. Clin. Invest. 109, 571-577. (Pubitemid 34204834)
31. Cone, R., (2005) Mucus. In Mucosal Immunology, 3rd ed. (, Michael, W. S., Strober, W., Bienenstock, J., McGhee, J. R., and, Mayer, L., eds.). pp. 49-72, Elsevier Academic press, San Diego.
32. Lai, S. K., O'Hanlon, D. E., Harrold, S., Man, S. T., Wang, Y. Y., Cone, R., and, Hanes J,. (2007) Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus. Proc. Natl. Acad. Sci. USA 104, 1482-1487. (Pubitemid 46214616)
33. Lai, S. K., Wang, Y. Y., and, Hanes, J., (2009) Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv. Drug Deliv. Rev. 61, 158-171.
34. Roberts, P. C., and, Compans, R. W., (1998) Host cell dependence of viral morphology. Proc. Natl. Acad. Sci. USA 95, 5746-5751. (Pubitemid 28224167)
35. Geng, Y., Dalhaimer, P., Cai, S. S., Tsai, R., Tewari, M., Minko, T., and, Discher, D. E,. (2007) Shape effects of filaments versus spherical particles in flow and drug delivery. Nat. Nanotechnol. 2, 249-255. (Pubitemid 46739812)
36. Geisbert, T. W., and, Jahrling, P. B., (2004) Exotic emerging viral diseases: progress and challenges. Nat. Med. 10, S110-S121. (Pubitemid 40018234)
37. Siekmeier, R., and, Scheuch, G., (2008) Inhaled insulin-does it become reality? J. Physiol. Pharmacol. 59, 81-113.
38. Walvoord, E. C., de la Pena, A., Park, S., Silverman, B., Cuttler, L., Rose, S. R., Cutler, G., Drop, S., and, Chipman, J. J,. (2009) Inhaled growth hormone (GH) compared with subcutaneous GH in children with GH deficiency: pharmacokinetics, pharmacodynamics, and safety. J. Clin. Endocr. Metab. 94, 2052-2059.
39. Clark, A., Kuo, M. C., Newman, S., Hirst, P., Pitcairn, G., and Pickford, M. (2008) A comparison of the pulmonary bioavailability of powder and liquid aerosol formulations of salmon calcitonin. Pharm. Res. 25, 1583-1590.
40. Codrons, V., Vanderbist, F., Verbeeck, R. K., Arras, M., Lison, D., Preat, V., and, Vanbever, R,. (2003) Systemic delivery of parathyroid hormone (1-34) using inhalation dry powders in rats. J. Pharm. Sci. 92, 938-950. (Pubitemid 36523439)
41. Morley, P., Bishop, J., Anderson, R., Barclay, C. L., Krause, D., Morelli, G., Newhouse, M., Sadrzadeh, N., and, Eldon, M,. (2007) Pulmonary delivery of the parathyroid hormone analogue Ostabolin-C (TM) stimulates markers of bone formation in postmenopausal women. J. Bone Miner. Res. 22, S1 - S127.
42. Thipphawong, J., (2006) Inhaled cytokines and cytokine antagonists. Adv. Drug Deliv. Rev. 58, 1089-1105. (Pubitemid 44709268)
43. Patton, J. S., Trinchero, P., and, Platz, R. M., (1994) Bioavailability of pulmonary delivered peptides and proteins-alpha-interferron, calcitonins and parathyroid hormones J. Control. Release 28, 79-85.
44. Taljanski, W., Pierzynowski, S. G., Lundin, P. D. P., Westrom, B. R., Eirefelt, S., Podlesny, J., Dahlback, M., SiwinskaGolebiowska, H., and, Karlsson, B. W,. (1997) Pulmonary delivery of intratracheally instilled and aerosolized cyclosporine A to young and adult rats. Drug. Metab. Dispos. 25, 917-920. (Pubitemid 27357688)
45. Okamoto, C. T., (1998) Endocytosis and transcytosis. Adv. Drug Deliv. Rev. 29, 215-228. (Pubitemid 28090042)
46. Kreyling, W. G., Hirn, S., and, Schleh, C., (2010) Nanoparticles in the lung. Nat. Biotechnol. 28, 1275-1276.
47. Geiser, M., and, Kreyling, W. G., (2010) Deposition and biokinetics of inhaled nanoparticles. Part. Fib. Toxicol. 7, 1-17.
48. Chen, J. M., Tan, M. G., Nemmar, A., Song, W. M., Dong, M., Zhang, G. L., and, Li, Y,. (2006) Quantification of extrapulmonary translocation of intratracheal-instilled particles in vivo in rats: effect of lipopolysaccharide. Toxicology 222, 195-201.
49. Choi, H. S., Ashitate, Y., Lee, J. H., Kim, S. H., Matsui, A., Insin, N., Bawendi, M. G., Semmler-Behnke, M., Frangioni, J. V., and, Tsuda, A,. (2010) Rapid translocation of nanoparticles from the lung airspaces to the body. Nat. Biotechnol. 28, 1300-1303.
50. Geng, Y., and, Discher, D. E., (2005) Hydrolytic degradation of poly(ethylene oxide)-block-polycaprolactone worm micelles. J. Am. Chem. Soc. 127, 12780-12781. (Pubitemid 41339148)
51. Yacobi, N. R., Malmstadt, N., Fazlollahi, F., DeMaio, L., Marchelletta, R., Hamm-Alvarez, S. F., Borok, Z., Kim, K. J., and, Crandall, E. D,. (2010) Mechanisms of alveolar epithelial translocation of a defined population of nanoparticles. Am. J. Resp. Cell. Mol. Biol. 42, 604-614.
52. Conner, S. D., and, Schmid, S. L., (2003) Regulated portals of entry into the cell. Nature 422, 37-44. (Pubitemid 36323287)
53. Predescu, D., Vogel, S. M., and, Malik, A. B., (2004) Functional and morphological studies of protein transcytosis in continuous endothelia. Am. J. Physiol. Lung Cell. Mol. Biol. 287, L895-L901. (Pubitemid 39391018)
54. Ding, B. S., Hong, N., Murciano, J. C., Ganguly, K., Gottstein, C., Christofidou-Solomidou, M., Albelda, S. M., Fisher, A. B., Cines, D. B., and, Muzykantov, V. R,. (2008) Prophylactic thrombolysis by thrombin-activated latent prourokinase targeted to PECAM-1 in the pulmonary vasculature. Blood 111, 1999-2006. (Pubitemid 351451510)
55. Shuvaev, V. V., Han, J. Y., Yu, K. J., Huang, S. H., Hawkins, B. J., Madesh, M., Nakada, M., and, Muzykantov, V. R,. (2011) PECAM-targeted delivery of SOD inhibits endothelial inflammatory response. FASEB J. 25, 348-357.
56. McIntosh, D. P., Tan, X. Y., Oh, P., and, Schnitzer, J. E., (2002) Targeting endothelium and its dynamic caveolae for tissue-specific transcytosis in vivo: a pathway to overcome cell barriers to drug and gene delivery. Proc. Natl. Acad. Sci. USA 99, 1996-2001. (Pubitemid 34169003)
57. Pardridge, W. M., (2003) Blood-brain barrier genomics and the use of endogenous transporters to cause drug penetration into the brain. Curr. Opin. Drug Discov. Dev. 6, 683-691. (Pubitemid 37287937)